Accessibility Menu
Asp Isotopes logo

Asp Isotopes(NASDAQ) ASPI

Current Price$3.90
Market Cap$508.65MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2022)+51%
5 YearN/A
1 Year-60%
1 Month-45%
Asp Isotopes last closing stock price
MetricPriceDate
Last closeUSD 3.872026-07-24
Asp Isotopes stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-0.13%USD 3.882026-07-17
1 month-45.18%USD 7.062026-06-24
3 month-27.66%USD 5.352026-04-24
Year to date-27.66%USD 5.352025-12-31
1 year-59.94%USD 9.662025-07-24
3 year+437.5%USD 0.722023-07-25
Since inception+51.31%USD 2.672022-11-10

Asp Isotopes Financials at a Glance

Market Cap

$508.65MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$26.93M

Net Income (TTM)

-$173.52M

EPS (TTM)

-$2.07

P/E Ratio

-1.95

Dividend

$0.00

Beta (Volatility)

2.56 (High)

Price

$3.90

Volume

92,485

Open

$3.98

Previous Close

$3.90

Daily Range

$3.88 - $4.04

52-Week Range

$3.61 - $14.49

Estimated Earnings Date

Aug 14, 2026

ASPI News

No articles available.

ASPI: Motley Fool Moneyball Superscore

47

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Asp Isotopes

ASP Isotopes makes special materials called isotopes for medicine and energy. Hospitals use these isotopes for medical scans and cancer treatment. Energy companies use them to help produce cleaner electricity.

Isotopes in Action: What ASP Sells

  • Medical Isotopes (100% of revenue as of June 30, 2025): Supplies materials for medical imaging and cancer therapy, mainly through PET Labs in South Africa.
  • Advanced Nuclear Fuels (0% revenue): Develops uranium-based fuels for next-generation nuclear reactors, not yet generating sales.
  • Specialty Isotopes: Produces Carbon-14 for pharmaceuticals and Silicon-28 for advanced computer chips and quantum computing.
  • Radiopharmaceuticals: Offers nuclear medical doses for PET scans, serving hospitals and clinics.
  • Emerging Isotopes: Researches new isotopes for healthcare, semiconductors, and clean energy markets.

Growth Spurts: How ASP Isotopes Expands

  • Acquired 51% of PET Labs Pharmaceuticals in 2023 to enter medical isotope production.
  • Announced plans in 2025 to acquire Renergen Limited, a helium and natural gas producer.
  • Commenced production of commercial samples and are beginning commercial production at three enrichment plants in South Africa in 2025, with expected commercial supply during the fourth quarter of 2025.
  • Signed supply and loan agreements with TerraPower in 2025 for advanced nuclear fuel projects.
  • Invested in IsoBio and planned a spin-out of Quantum Leap Energy in 2025.

What Makes ASP Isotopes Stand Out

ASP Isotopes operates globally, with production in South Africa and expansion plans in Iceland and the U.S. The company uses proprietary enrichment technologies to create specialized isotopes for niche markets. Its focus on both medical and energy applications helps diversify its business model.

Five Things You Need to Know

  • Revenue was approximately $1.2 million in Q2 2025, up 17.2% year-on-year.
  • Gross profit reached $572,098 in Q2 2025, up 35.9% from Q2 2024.
  • Net loss was $75.1 million in Q2 2025, mainly from a $63.8 million note adjustment.
  • Cash and cash equivalents totaled $67.7 million as of June 30, 2025.
  • All revenue in 2025 came from medical isotopes; nuclear fuels segment had no sales yet.

Bottom Line

ASP Isotopes has shifted from research to early commercial production, focusing on medical and energy isotopes. The company remains in a high-investment phase, with future growth tied to new facilities and product launches.

AI Generated • Apr 16, 2026

Industry

Chemicals

Sector

Materials

Employees

271

CEO

Paul E. Mann, CFA

Website

www.aspisotopes.com

Headquarters

Dallas, TX 33432, US

ASPI Financials

Key Financial Metrics (TTM)

Gross Margin

17.62%

Operating Margin

-275.28%

Net Income Margin

-644.41%

Return on Equity

-117.16%

Return on Capital

-13.61%

Return on Assets

-29.53%

Earnings Yield

-51.28%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$508.65MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

125.90M

Volume

92.48K

Avg. Volume

4.93M

Financials (TTM)

Gross Profit

$4.74M

Operating Income

-$74.13M

EBITDA

-$170.61M

Operating Cash Flow

-$52.37M

Capital Expenditure

-$13.43M

Free Cash Flow

-$65.80M

Cash & ST Invst.

$290.52M

Total Debt

$261.84M

Asp Isotopes Performance Analysis

Asp Isotopes annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 0N/A
20232023-12-31USD 433,026N/A
20242024-12-31USD 4,144,226857.0%
20252025-12-31USD 23,849,000475.5%
Asp Isotopes sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-308.8%
Q32025-09-30308.0%
Q42025-12-31240.7%
Q12026-03-31-74.9%
Asp Isotopes annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.1481.4%
20232023-12-31USD -0.49257.7%
20242024-12-31USD -0.6328.1%
20252025-12-31USD -2.11234.4%
Asp Isotopes sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-758.3%
Q32025-09-3085.4%
Q42025-12-31-460.0%
Q12026-03-3193.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$4.18M

+279.4%

Gross Profit

$1.67M

+409.7%

Gross Margin

39.86%

N/A

Market Cap

$508.65MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.88M

N/A

Employees

271

N/A

Net Income

-$6.88M

+18.6%

EBITDA

-$21.83M

-163.2%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$290.52M

+419.1%

Total Debt

$261.84M

+581.0%

Accounts Receivable

$4.59M

+563.1%

Inventory

$1.37M

+299.5%

Long Term Debt

$207.62M

+461.7%

Short Term Debt

$54.22M

+3547.1%

Return on Assets

-29.53%

N/A

Return on Invested Capital

-14.33%

N/A

Free Cash Flow

-$23.90M

-332.2%

Operating Cash Flow

-$17.76M

-460.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GSMFerroglobe PLC
$3.36+0.30%
UAMYUnited States Antimony Corporation
$5.17-6.17%
WLKPWestlake Chemical Partners LP
$22.05+0.18%
BAKBraskem S.A.
$2.46-0.40%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$92.32-0.08%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
SOFISoFi Technologies
$16.46-0.01%
FFord Motor Company
$14.37+0.02%

Questions About ASPI

What is the current price of Asp Isotopes?

Asp Isotopes is trading at $3.90 per share.

What is the 52-week range for Asp Isotopes?

Over the past 52 weeks, Asp Isotopes has traded between $3.61 and $14.49.

How much debt does Asp Isotopes have?

As of the most recent reporting period, Asp Isotopes reported total debt of $261.84M.

How much cash does Asp Isotopes have on hand?

Asp Isotopes reported $210.11M in cash and cash equivalents in its most recent financial results.

What is Asp Isotopes’s dividend yield?

Asp Isotopes does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services